Hyperhomocysteinemia impairs angiogenesis in response to hindlimb ischemia

Arterioscler Thromb Vasc Biol. 2000 Dec;20(12):2579-85. doi: 10.1161/01.atv.20.12.2579.

Abstract

Hyperhomocysteinemia (HH) is an independent risk factor for atherosclerosis, including peripheral arterial occlusive disease (PAOD). Because angiogenesis and collateral vessel formation are important self-salvage mechanisms for ischemic PAOD, we examined whether HH modulates angiogenesis in vivo in a rat model of hindlimb ischemia. Rats were divided into 3 groups: the control group was given tap water, the HH group was given water containing L-methionine (1 g x kg(-1) x d(-1)), and the HH+L-arg group was given water containing methionine (1 g x kg(-1) x d(-1)) and l-arginine (2.25 vol%). At day 14 of the dietary modifications, the left femoral artery and vein were excised, and the extent of angiogenesis and collateral vessels in the ischemic limb were examined for 4 weeks. Plasma homocysteine levels significantly increased (P:<0.001), and plasma and tissue contents of nitrite+nitrate as well as tissue cGMP levels significantly decreased in the HH group compared with the control group (P:<0.01). Laser Doppler blood flowmetry (LDBF) revealed a significant decrease in the ischemic/normal limb LDBF ratio in the HH group at days 7, 14, 21, and 28 (P:<0.01 versus control). Angiography revealed a significant decrease in the angiographic score in the HH group at day 14 (P:<0.001 versus control). Immunohistochemistry of ischemic tissue sections showed a significant reduction in the capillary density in the HH group (P:<0. 001 versus control). Oral l-arginine supplementation in rats with HH (HH+L-arg) restored the decreased plasma and tissue nitrite+nitrate and cGMP contents (P:<0.05) as well as angiogenesis, as assessed by LDBF (P:<0.05 versus HH), angiographic score (P:<0.01 versus HH), and capillary density (P:<0.001 versus HH). In summary, HH impaired ischemia-induced angiogenesis and collateral vessel formation in a rat model of hindlimb ischemia in vivo. The mechanism of the HH-induced impairment of angiogenesis might be mediated in part by a reduced bioactivity of endogenous NO in the HH state.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiography
  • Animals
  • Arginine / therapeutic use
  • Blood Pressure
  • Body Weight
  • Collateral Circulation
  • Cyclic GMP / metabolism
  • Disease Models, Animal
  • Heart Rate
  • Hindlimb / blood supply*
  • Homocysteine / blood
  • Hyperhomocysteinemia / complications
  • Hyperhomocysteinemia / physiopathology*
  • Immunohistochemistry
  • Ischemia / blood
  • Ischemia / complications*
  • Ischemia / drug therapy
  • Laser-Doppler Flowmetry
  • Muscle, Skeletal / metabolism
  • Neovascularization, Physiologic
  • Nitrates / blood
  • Nitrites / blood
  • Rats
  • Regional Blood Flow
  • Time Factors

Substances

  • Nitrates
  • Nitrites
  • Homocysteine
  • Arginine
  • Cyclic GMP